From Name:
From Email:
To Name:
To Email:

Optional Message:

Circadian teams with Cincinnati Children's Hospital in US to
develop blood test diagnostic for lung disease

from TradingMarkets

Circadian Technologies has announced that it has partnered with Cincinnati Children's Hospital Medical Centre (CCHMC) to develop and market a blood test to diagnose LAM, a serious lung disease that strikes women, usually in their child bearing years. The diagnostic is being developed following the discovery that high levels of vascular endothelial growth factor-D, or VEGF-D to which Circadian owns intellectual property rights holds the key to detecting the disease, the Companies said. The test is expected to be available in the U.S. from early 2011, and Circadian will work with CCHMC and other groups throughout the world to make the test available in other global markets. The findings of the diagnostic link between LAM and VEGF-D were made by a team of scientists at the University of Cincinnati (UC) and CCHMC led by Dr. Lisa Young and Dr. Frank McCormack, Director of Pulmonary, Critical Care and Sleep Medicine at UC and were published in CHEST. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063